29th May 2019 12:38
LONDON (Alliance News) - Hutchison China Meditech Ltd on Wednesday said its shareholders have approved a subdivision of shares at its extraordinary general meeting.
The pharmaceutical company confirmed that each existing share of USD1.00 will be subdivided into 10 new shares of USD0.10 each, with effect from Thursday. Trading on AIM for the existing shares will therefore cease after the market close on Wednesday.
The new shares will start trading under new ISIN KYG4672N1198.
Following the subdivision, Hutchison China Meditech will have 666.7 million shares overall.
The stock was trading 3.2% higher on Wednesday in London at 4,400.00 pence a share.
Related Shares:
Hutchmed